ATE452197T1 - Für orotat-transporter codierende markergene - Google Patents
Für orotat-transporter codierende markergeneInfo
- Publication number
- ATE452197T1 ATE452197T1 AT05700642T AT05700642T ATE452197T1 AT E452197 T1 ATE452197 T1 AT E452197T1 AT 05700642 T AT05700642 T AT 05700642T AT 05700642 T AT05700642 T AT 05700642T AT E452197 T1 ATE452197 T1 AT E452197T1
- Authority
- AT
- Austria
- Prior art keywords
- marker gene
- transporters
- genes encoding
- marker genes
- cell
- Prior art date
Links
- 239000003550 marker Substances 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 title abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108700026220 vif Genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Primary Cells (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Editing Of Facsimile Originals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200400227 | 2004-02-13 | ||
| PCT/DK2005/000092 WO2005078106A1 (en) | 2004-02-13 | 2005-02-11 | Orotate transporter encoding marker genes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE452197T1 true ATE452197T1 (de) | 2010-01-15 |
Family
ID=34854486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05700642T ATE452197T1 (de) | 2004-02-13 | 2005-02-11 | Für orotat-transporter codierende markergene |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20070087351A1 (de) |
| EP (1) | EP1716237B1 (de) |
| CN (1) | CN1918301A (de) |
| AT (1) | ATE452197T1 (de) |
| DE (1) | DE602005018326D1 (de) |
| DK (1) | DK1716237T3 (de) |
| WO (1) | WO2005078106A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110564660A (zh) * | 2019-09-18 | 2019-12-13 | 苏州华赛生物工程技术有限公司 | 生产乳清酸的重组微生物及方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115838645B (zh) * | 2022-09-15 | 2024-03-08 | 天津大学 | 一种高产乳清酸的酵母菌株及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2807446B1 (fr) * | 2000-04-11 | 2005-05-06 | Agronomique Inst Nat Rech | Genomes de lactococcus lactis, polypeptides et utilisations |
-
2005
- 2005-02-11 WO PCT/DK2005/000092 patent/WO2005078106A1/en not_active Ceased
- 2005-02-11 DE DE602005018326T patent/DE602005018326D1/de not_active Expired - Lifetime
- 2005-02-11 AT AT05700642T patent/ATE452197T1/de not_active IP Right Cessation
- 2005-02-11 EP EP05700642A patent/EP1716237B1/de not_active Expired - Lifetime
- 2005-02-11 CN CNA2005800048758A patent/CN1918301A/zh active Pending
- 2005-02-11 DK DK05700642.1T patent/DK1716237T3/da active
- 2005-02-11 US US10/586,932 patent/US20070087351A1/en not_active Abandoned
-
2010
- 2010-01-15 US US12/688,303 patent/US8658357B2/en not_active Expired - Fee Related
-
2014
- 2014-01-27 US US14/165,227 patent/US20140141447A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110564660A (zh) * | 2019-09-18 | 2019-12-13 | 苏州华赛生物工程技术有限公司 | 生产乳清酸的重组微生物及方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DK1716237T3 (da) | 2010-04-26 |
| EP1716237A1 (de) | 2006-11-02 |
| US20100120052A1 (en) | 2010-05-13 |
| US20070087351A1 (en) | 2007-04-19 |
| EP1716237B1 (de) | 2009-12-16 |
| WO2005078106A1 (en) | 2005-08-25 |
| US8658357B2 (en) | 2014-02-25 |
| CN1918301A (zh) | 2007-02-21 |
| US20140141447A1 (en) | 2014-05-22 |
| DE602005018326D1 (de) | 2010-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ602351A (en) | Axmi-115, axmi-113, axmi-005, axmi-163 and axmi-184 : vip3a insecticidal proteins from bacillus thuringiensis and methods for their use | |
| NZ600690A (en) | Fkbp-l and uses thereof | |
| ATE462000T1 (de) | Verfahren zur herstellung von l-arginin, l- ornithin oder l-citrullin | |
| IN2014CN02050A (de) | ||
| ES2691539T3 (es) | Luciferasas de Oplophorus sintéticas con mayor emisión de luz | |
| DE60335794D1 (de) | Multigene vectoren und methoden für eine erhöhte expression von rekombinanten polypeptiden | |
| NZ596459A (en) | Phytases, nucleic acids encoding them and methods for making and using them | |
| AR049177A1 (es) | Polipeptidos y conjugados de interferon-alfa | |
| NZ601099A (en) | Use of vip3ab in combination with cry1ca for management of resistant insects | |
| BRPI0509023A (pt) | nitrila hidratase de rhodococcus | |
| BR112022012057A2 (pt) | Novos métodos de entrega celular | |
| ATE536409T1 (de) | Unkrautbekämpfungsstoffwechselproteine, gene dafür und ihre verwendung | |
| ATE362544T1 (de) | Polypeptide mit alpha-h alpha amino acid amide racemase aktivitität und nukleinsäuren kodierend dafür | |
| ES2489715T3 (es) | Procedimiento para la produccíón de colágeno humano de tipo II | |
| ATE452197T1 (de) | Für orotat-transporter codierende markergene | |
| ES2557938T3 (es) | Antagonistas de resistina y su uso | |
| JP2009240233A5 (de) | ||
| ATE490266T1 (de) | In zellen eindringende peptide als träger für moleküle | |
| ATE421971T1 (de) | Isostere transformation | |
| NO20082864L (no) | Nytt polypeptid med esteraseaktivitet og rekombinant esterase samt anvendelse derav | |
| AR039021A1 (es) | Gen humano de la proteasa desubiquitinante del cromosoma 7 y su ortologo murino | |
| MX2025013582A (es) | Proteina insecticida y uso de la misma | |
| ATE382698T1 (de) | Ein gen kodierend für vitamin b6-phosphat- phosphatase und deren verwendung | |
| ATE517181T1 (de) | Rekombinante carboxypeptidase b | |
| ATE489463T1 (de) | Polypeptid mit einer delta-5-fettsäure- desaturierungsaktivität, für das polypeptid codierendes polynukleotid und verwendung davon. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |